Academic Profiles — SynBio Canada

Dr. Vincent Martin

We are synthetic biologists with a strong penchant for metabolic engineering and industrial strain improvement. We like yeast but will play with other unicellular bugs as well.

Dr. Scott McComb

Chimeric antigen receptor T cells (CAR-T) are an exciting new avenue to redirect immune cells to target and kill cancer. While breakthroughs in CAR-T therapy have led to life-saving treatments for patients with previously incurable leukemia, such therapies have been less successful against solid tumours.

OntarioBenjamin ScottApril 18, 2018#mammalian, #geneediting, #therapeutics, #academic

Dr. Moira McQueen

As a bioethicist, I am interested in the science and development of synthetic biology and in ethical questions that arise from its use, as well as in its impact on health care, the workforce and the environment.

OntarioBenjamin ScottApril 6, 2018#geneediting, #therapeutics, #academic, #policy

Dr. Gabriel Moreno-Hagelsieb

My work is about gene-product interactions, which can be represented as networks and modules.

OntarioBenjamin ScottApril 3, 2018#bacteria, #modeling, #academic

Dr. Sebastien Rodrigue

My laboratory is mainly interested in microbial systems and synthetic biology. We use and develop cutting-edge approaches to understand and engineer bacterial cells.

QuebecBenjamin ScottFebruary 28, 2018#bacteria, #modeling, #therapeutics, #academic

Dr. Ahmad Saleh

Synthetic biology strategies for the biosynthesis of fine chemicals, especially lipid-based drugs and biofuels

Dr. Rebecca Shapiro

My research group at the University of Guelph is developing new CRISPR-based platforms for functional genomic analysis in fungal pathogens.

OntarioBenjamin ScottFebruary 16, 2018#yeast, #geneediting, #therapeutics, #academic

Dr. Valerie Ward

We aim to engineer microalgae to produce proteins for medical and industrial uses as well as engineer metabolic pathways in microbial platforms for the production of isoprenoids.

OntarioBenjamin ScottFebruary 5, 2018#bacteria, #cellfree, #metabolicengineering, #therapeutics, #greentech, #academic

Dr. Vikramaditya Yadav

The principal theme of Prof. Yadav’s research is the utilization of metabolic & enzyme engineering to investigate and customize novel biosynthetic enzymes that can convert biomass-derived feedstocks into value-added chemicals.

Dr. Peter Zandstra

Research in the Zandstra Laboratory is focused on the generation of functional tissue from somatic and pluripotent stem cells. Our quantitative, technology-driven approach strives to gain new insights into fundamental mechanisms that control stem cell fate and to develop robust technologies for the propagation of stem cells and their derivatives.

British ColumbiaBenjamin ScottFebruary 2, 2018#mammalian, #genecircuits, #geneediting, #therapeutics, #academic

Dr. Wei Zhang

My lab will open in July 2018 at the Department of Molecular and Cellular Biology, University of Guelph. We are creating synthetic proteins using bimolecular engineering approaches to accelerate understanding of biology and development of novel therapeutics.

OntarioBenjamin ScottFebruary 1, 2018#mammalian, #virus, #proteinengineering, #geneediting, #therapeutics, #academic

SynBioApps NSERC-CREATE program

SynBioApps offers graduate training in the various technologies of synthetic biology, including work in Concordia University’s Genome Foundry.